Kazakh scientists at
the Nuclear Medicine Center in Astana are developing medicines that enable the
early diagnosis of brain and prostate cancer. Using minimal doses of radioisotopes,
these drugs help detect tumors early, allowing doctors to prescribe timely and
effective treatment. The Medical Centre Hospital of the President’s Affairs
Administration offers advanced diagnostic capabilities, where patients are
injected with a radioactive drug for full-body examination.
«Nuclear energy can be applied in various
sectors of the economy, for example, radiopharmaceuticals, which are used for
diagnostics and treatment of oncological diseases. The country has the
necessary resources for this, the same radioisotopes. With not only raw
materials but also new technologies produced within our country, there is
potential to make a huge contribution to the economy by entering the global
market,» said Sayabek Sakhiyev, Director General of the Institute of Nuclear
Physics.
The Nuclear Medicine
Center has developed seven different radiopharmaceuticals and plans to create
two more within the next two years.
